Literature DB >> 28346920

Microbial Composition of the Initial Colonization of Newborns.

Samuli Rautava1.   

Abstract

Early-life interaction with indigenous intestinal microbes is a prerequisite for healthy immune and metabolic maturation. Human infants acquire their gut microbiota predominantly from the mother. A considerable inoculum of microbes is received by the neonate during vaginal delivery. Recent observations suggest that human gut colonization may be initiated prenatally by microbes in amniotic fluid, but the significance of this phenomenon remains unknown. After birth, neonatal gut colonization is guided by human milk factors, which selectively promote the growth of specific microbes, as well as by live microbes present in human milk. Aberrant gut colonization in early life has been associated with an increased risk of noncommunicable diseases in later life. Epidemiological and experimental studies suggest a causal relationship between early-life gut microbiota perturbations and disease risk. Perinatal antibiotic exposure, cesarean section delivery, postnatal antibiotic administration, and formula feeding, which may disrupt intestinal microecology, have been associated with disease development in later life. The modulation of gut microbiota in the perinatal period by pre- and probiotics, for example, may offer a means to reduce the risk of chronic diseases.
© 2017 Nestec Ltd., Vevey/S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28346920     DOI: 10.1159/000455209

Source DB:  PubMed          Journal:  Nestle Nutr Inst Workshop Ser        ISSN: 1664-2147


  2 in total

Review 1.  The crucial role of early-life gut microbiota in the development of type 1 diabetes.

Authors:  He Zhou; Lin Sun; Siwen Zhang; Xue Zhao; Xiaokun Gang; Guixia Wang
Journal:  Acta Diabetol       Date:  2020-07-25       Impact factor: 4.280

2.  Effect of intestinal microecology on postnatal weight gain in very preterm infants in intensive care units.

Authors:  Ying-Xue Ding; Shou-Ni Wang; Hong Cui; Li-Na Jiang
Journal:  Gut Pathog       Date:  2021-08-02       Impact factor: 4.181

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.